Summit Trail Advisors, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1698478 NEW YORK, NY

Position in VRTX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$3,236,075

+$943,434 QoQ

Shares Held

7,247

+43.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Summit Trail Advisors, LLC holds $27,745,492 across 30 Biotechnology names. VRTX ranks #2 (11.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	24,830	$4,694,111
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	7,247	$3,236,075
3	INCY	Incyte Corp	27,019	$2,543,028
4	REGN	Regeneron Pharmaceuticals, Inc.	3,017	$2,331,054
5	TECH	BIO-TECHNE Corp	35,002	$1,829,204
6	RPRX	Royalty Pharma plc	33,611	$1,612,319
7	ALNY	Alnylam Pharmaceuticals, Inc.	3,598	$1,190,470
8	INSM	INSMED Inc	6,714	$1,097,873

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,236,075	7,247	+43.3%	Shares	Sole	2026-05-12
2025-12-31	$2,292,641	5,057	-7.8%	Shares	Sole	2026-02-17
2025-09-30	$2,147,753	5,484	-6.6%	Shares	Sole	2025-11-14
2025-06-30	$2,613,769	5,871	+11.1%	Shares	Sole	2025-08-14
2025-03-31	$2,561,304	5,283	+19.8%	Shares	Sole	2025-04-28
2024-12-31	$1,775,504	4,409	+35.1%	Shares	Sole	2025-01-29
2024-09-30	$1,518,021	3,264	+13.3%	Shares	Sole	2024-11-12
2024-06-30	$1,350,382	2,881	+14.8%	Shares	Sole	2024-08-13
2024-03-31	$1,048,787	2,509	+19.5%	Shares	Sole	2024-04-23
2023-12-31	$854,062	2,099	-11.0%	Shares	Sole	2024-02-06
2023-09-30	$820,318	2,359	+41.5%	Shares	Sole	2023-10-30
2023-06-30	$586,633	1,667	+130.6%	Shares	Sole	2023-07-25
2023-03-31	$227,795	723	—	Shares	Sole	2023-05-04
No filing history on record for this holder in this stock.